<DOC>
	<DOCNO>NCT02599571</DOCNO>
	<brief_summary>The purpose study investigate impact different nicotine level cigarettes individual ADHD .</brief_summary>
	<brief_title>Effects Nicotine Reduction Smoking Behavior ADHD Smokers</brief_title>
	<detailed_description>The purpose study examine effect low nicotine content ( VLNC ) cigarettes smoke behavior , psychiatric symptom function , acceptability adverse outcomes young adult smoker ADHD . Participants attend screen session , 2 baseline session , 6 experimental session , 30 day follow-up visit . Participants ask smoke study cigarette provide 6 week .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Age 18 40 Smoke average 540 cigarette per day least 1 year Breath CO level &gt; 8 ppm ( ≤ 8 ppm , NicAlert Strip &gt; 6 ) Primary diagnosis ADHD , subtype assess CAADID ; TScore &gt; 65 one DSM V relevant scale ( Inattentive Symptoms , HyperactiveImpulsive Symptoms , Total Symptoms ADHD Index ) SelfReport version CAARS ; Clinician Rated ADHDRS score &gt; 24 . Cognitive functioning &gt; 80 assess KBITII Intention quit smoke next 30 day Currently seek treatment smoke cessation Currently use nicotine replacement therapy pharmacotherapies cessation aid ( intermittent use acceptable ) A quit attempt past 30 day result great 3 day abstinence Using tobacco product 9 day past 30 day Significant unstable medical condition ( significant change serious medical condition occur past 3 month include cardiovascular disease , COPD , cancer , determine study physician site ) Significant unstable psychiatric condition ( significant change psychiatric symptom past 3 month determine study physician site ) Any Axis I Psychiatric Disorder assess MINI significantly impair and/or would contraindicate participation study Psychiatric medication change past 3 month include new prescription , change dosages discontinuation medication Positive toxicology screen follow drug : cocaine , opiates , methadone , benzodiazepine , barbiturate , amphetamine , methamphetamine , PCP ( Marijuana test exclusionary criterion , participant valid prescription opiate , benzodiazepine , barbiturate , amphetamine methadone exclude , participant fail toxicology screen allow re‐screen . These participant need re‐consented rescreened ensure receive adequate informed consent . ) Breath alcohol level &gt; 0.01 ( Participants fail breath alcohol screen allow re‐screen . These participant need re‐consented rescreened ensure receive adequate informed consent . ) Current diagnosis DSM alcohol drug use disorder ( except nicotine ) Pregnant , try become pregnant breastfeed Smoking 'roll cigarette ' exclusively Currently take anticonvulsant medication include : Phenytoin [ Brand Name : Dilantin ] , Carbamazepine [ Brand Name : Tegretol , Carbatrol , Equetro , Epitol ] , Oxcarbazepine [ Brand Name : Trileptal ] , Primidone [ Brand Name : Mysoline ] , Phenobarbital CO read &gt; 80 ppm Systolic BP 90 160 ( If 90 asymptomatic . Participants fail blood pressure allow re‐screen . ) Diastolic BP 50 100 ( If 50 asymptomatic . Participants fail blood pressure allow re‐screen . ) Heart rate 45 115 bpm ( If 45 asymptomatic . Participants fail heart rate allow re‐screen . ) Indicating suicidal ideation past month suicide attempt past 10 year . Inability independently read comprehend consent form write study material measure . Having participate research study past three month participant : Smoked cigarette his/her usual brand cigarette one day , use tobacco product beyond normal use one day , use nicotine replacement product smoke cessation medication one day Any previous experience use SPECTRUM cigarette</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>